(Q45972821)

English

Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

author name string

H Denison

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

C Nilsson

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

M Kujacic

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

L Löfgren

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

C Karlsson

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

M Knutsson

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

J W Eriksson

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

publication date

30 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

15

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

136-143

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

Global estimates of the prevalence of diabetes for 2010 and 2030

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

Gut triglyceride production

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

Intestinal lipid absorption and transport

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

Incremental area under response curve more accurately describes the triglyceride response to an oral fat load in both healthy and type 2 diabetic subjects.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12002

21 January 2018

Identifiers

10.1111/DOM.12002

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22950654

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45972821&oldid=1621169242"